152 related articles for article (PubMed ID: 8877768)
1. Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
Lu Q; Zhu Z; Weng J
J Med Virol; 1996 Aug; 49(4):333-5. PubMed ID: 8877768
[TBL] [Abstract][Full Text] [Related]
2. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
[TBL] [Abstract][Full Text] [Related]
4. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
5. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of inactivated vaccine containing cyto-hemagglutinin against epidemic hemorrhagic fever in rabbits.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Fu GM
Chin Med J (Engl); 1989 Aug; 102(8):602-5. PubMed ID: 2576866
[TBL] [Abstract][Full Text] [Related]
7. An immune adherence assay for discrimination between etiologic agents of hemorrhagic fever with renal syndrome.
Sugiyama K; Matsuura Y; Morita C; Shiga S; Akao Y; Komatsu T; Kitamura T
J Infect Dis; 1984 Jan; 149(1):67-73. PubMed ID: 6141206
[TBL] [Abstract][Full Text] [Related]
8. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
Chu YK; Jennings GB; Schmaljohn CS
J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542
[TBL] [Abstract][Full Text] [Related]
9. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
[TBL] [Abstract][Full Text] [Related]
10. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
[TBL] [Abstract][Full Text] [Related]
11. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
Hooper JW; Custer DM; Smith J; Wahl-Jensen V
Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).
Cho HW; Howard CR
Vaccine; 1999 Jun; 17(20-21):2569-75. PubMed ID: 10418904
[TBL] [Abstract][Full Text] [Related]
13. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
Gong ZY; Weng JQ; Zhao ZY; Chen YT; Zhu AG; Fu GM; Fang CF; Zhu ZY; Chen EF; Wang CZ; Wang W; Lei LH; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):400-2. PubMed ID: 15231163
[TBL] [Abstract][Full Text] [Related]
14. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
[TBL] [Abstract][Full Text] [Related]
15. Hemagglutination-inhibiting antibody in hemorrhagic fever with renal syndrome.
Tsai TF; Tang YW; Hu SL; Ye KL; Chen GL; Xu ZY
J Infect Dis; 1984 Dec; 150(6):895-8. PubMed ID: 6150063
[TBL] [Abstract][Full Text] [Related]
16. Antiviral neutralizing antibody to Hantaan virus as determined by plaque reduction technique.
Takenaka A; Gibbs CJ; Gajdusek DC
Arch Virol; 1985; 84(3-4):197-206. PubMed ID: 2859845
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunofluorescence and hemagglutination inhibition tests and enzyme-linked immunosorbent assay for detection of serum antibody in rats infected with hemorrhagic fever with renal syndrome virus.
Takahashi Y; Okuno Y; Yamanouchi T; Takada N; Yamanishi K
J Clin Microbiol; 1986 Nov; 24(5):712-5. PubMed ID: 2877007
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
Hooper JW; Custer DM; Thompson E; Schmaljohn CS
J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
[TBL] [Abstract][Full Text] [Related]
19. Distribution of hantavirus serotypes Hantaan and Seoul causing hemorrhagic fever with renal syndrome and identification by hemagglutination inhibition assay.
Tang YW; Li YL; Ye KL; Xu ZY; Ruo SL; Fisher-Hoch SP; McCormick JB
J Clin Microbiol; 1991 Sep; 29(9):1924-7. PubMed ID: 1685497
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
